ursodeoxycholic acid has been researched along with Gastroesophageal Reflux in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Derbak, M; Petrichko, O; Sirchak, Y; Stan, M | 1 |
| Davydkin, IL; Osadchuk, AM | 1 |
| Luzina, EV; Tomina, EA; Zhilina, AA | 1 |
| Stamp, D | 1 |
| Del Grande, JC; Ferreira, AT; Herbella, FA; Patti, MG; Rocha, MS; Tahan, C | 1 |
| Adhami, T; Goldblum, JR; Richter, JE; Vaezi, MF | 1 |
| Ajani, J; Buttar, NS; Chen, CT; Chou, CK; Guha, S; Hsu, JM; Huang, P; Hung, MC; Izzo, JG; Kuo, HP; Lee, DF; Sun, HL; Wang, KK; Wei, Y; Wu, TT; Yen, CJ | 1 |
1 review(s) available for ursodeoxycholic acid and Gastroesophageal Reflux
| Article | Year |
|---|---|
[Obesity and diseases of digestive organs].
Topics: Body Mass Index; Cholagogues and Choleretics; Cholelithiasis; Diet Therapy; Endoscopy, Gastrointestinal; Fatty Liver; Gastroesophageal Reflux; Health Behavior; Humans; Life Style; Non-alcoholic Fatty Liver Disease; Obesity; Risk Factors; Ursodeoxycholic Acid | 2013 |
1 trial(s) available for ursodeoxycholic acid and Gastroesophageal Reflux
| Article | Year |
|---|---|
[Using ursodez in the treatment of refractory form of gastroesophageal reflux disease].
Topics: Adult; Aged; Cholagogues and Choleretics; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Digestive System; Gastroesophageal Reflux; Humans; Middle Aged; Omeprazole; Proton Pump Inhibitors; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
5 other study(ies) available for ursodeoxycholic acid and Gastroesophageal Reflux
| Article | Year |
|---|---|
INFLUENCE OF URSODEOXYCHOLIC ACID ON THE CHOLECYSTOKININ LEVELS IN PATIENTS WITH GASTRO-ESOPHAGEAL REFLUX DISEASE AND TYPE 2 DIABETES MELLITUS.
Topics: Cholecystokinin; Diabetes Mellitus, Type 2; Gastroesophageal Reflux; Humans; Ursodeoxycholic Acid | 2021 |
Acid suppression therapy should be reevaluated; liposome technology may be a good replacement.
Topics: Animals; Delayed-Action Preparations; Evidence-Based Medicine; Gastroesophageal Reflux; Liposomes; Proton Pump Inhibitors; Rats; Treatment Outcome; Ursodeoxycholic Acid | 2016 |
Effects of ursodeoxycholic acid in esophageal motility and the role of the mucosa. An experimental study.
Topics: Animals; Esophageal Motility Disorders; Esophagus; Gastroesophageal Reflux; Gastrointestinal Motility; Guinea Pigs; Male; Mucous Membrane; Peristalsis; Ursodeoxycholic Acid | 2011 |
The role of gastric and duodenal agents in laryngeal injury: an experimental canine model.
Topics: Animals; Bile Acids and Salts; Cholagogues and Choleretics; Dogs; Gastroesophageal Reflux; Laryngeal Diseases; Larynx; Pepsin A; Trypsin; Ursodeoxycholic Acid; Vocal Cords | 2004 |
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Topics: Adenocarcinoma; Barrett Esophagus; Bile Acids and Salts; Cell Division; Chenodeoxycholic Acid; Esophageal Neoplasms; Gastroesophageal Reflux; Gene Expression Regulation, Neoplastic; Humans; Inflammation; NF-kappa B; Nitriles; Protein Kinases; RNA, Small Interfering; Sirolimus; Sulfones; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins; Ursodeoxycholic Acid | 2008 |